Cognitive Status of Adult Growth Hormone (GH)-Deficient Patients and GH-Induced Neuropsychological Changes

The Somatotrophic Axis in Brain Function

Volumn , Issue , 2006, Pages 287-300

  Deijen, Jan B ^a   Arwert, Lucia I ^b  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84871993002     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012088484-1/50025-2     Document Type: Chapter

References (81)

1. Abbott D., Rotnem D., Genel M., Cohen D.J. Cognitive and emotional functioning in hypopituitary short-statured children. Schizophr. Bull. 1982, 8:310-319.
2. Adem A., Jossan S.S., d'Argy R., Gillberg P.G., Nordberg A., Winblad B., Sara V. Insulin-like growth factor-I (IGF-1) receptors in the human brain: Quantitative autoradiographic localization. Brain Res. 1989, 503:299-303.
3. Aleman A., de Vries W.R., de Haan E.H., Verhaar H.J., Samson M.M., Koppeschaar H.P. Age-sensitive cognitive function, growth hormone and insulin-like growth factor-I plasma levels in healthy older men. Neuropsychobiology 2000, 41:73-78.
4. Aleman A., Verhaar H.J., de Haan E.H., de Vries W.R., Samson M.M., Drent M.L., van der Veen E.A., Koppeschaar H.P. Insulin-like growth factor-I and cognitive function in healthy older men. J. Clin. Endocrinol. Metab. 1999, 84:471-475.
5. Almqvist O., Thoren M., Saaf M., Eriksson O. Effects of growth hormone substitution on mental performance in adults with growth hormone deficiency: A pilot study. Psychoneuroendocrinology 1986, 11:347-352.
6. Arai Y., Hirose N., Yamamura K., Shimizu K., Takayama M., Ebihara Y., Osono Y. Serum insulin-like growth factor-I in centenarians: Implications of IGF-1 as a rapid turnover protein. J. Gerontol. A Biol. Sci. Med. Sci. 2001, 56:M79-M82.
7. Arwert L.I., Deijen J.B., Drent M.L. Effects of an oral mixture containing glycine, glutamine and niacin on memory, GH and IGF-I secretion in middle-aged and elderly subjects. Nutr. Neurosci. 2003, 6:269-275.
8. Bach M.A., Rockwood K., Zetterberg C., Thamsborg G., Hebert R., Devogelaer J.P., Christiansen J.S., Rizzoli R., Ochsner J.L., Beisaw N., Gluck O., Yu L., Schwab T., Farrington J., Taylor A.M., Ng J., Fuh V. The effects of MK-0677, an oral growth hormone secretagogue, in patients with hip fracture. J. Am. Geriatr. Soc. 2004, 52:516-523.
9. Baum H.B., Katznelson L., Sherman J.C., Biller B.M., Hayden D.L., Schoenfeld D.A., Cannistraro K.E., Klibanski A. Effects of physiological growth hormone (GH) therapy on cognition and quality of life in patients with adult-onset GH deficiency. J. Clin. Endocrinol. Metab. 1998, 83:3184-3189.
10. Baumann G. Growth hormone binding protein 2001. J. Pediatr. Endocrinol. Metab. 2001, 14:355-375.
11. Bleuler M. The psychopathology of acromegaly. J. Nerv. Ment. Dis. 1951, 113:497-511.
12. Brown K., Rodgers J., Johnstone H., Adams W., Clarke M., Gibson M., Cheetham T. Abnormal cognitive function in treated congenital hypopituitarism. Arch. Dis. Child. 2004, 89:827-830.
13. Buchanan C.M., Eccles J.S., Becker J.B. Are adolescents the victims of raging hormones: Evidence for activational effects of hormones on moods and behavior at adolescence. Psychol. Bull. 1992, 111:62-107.
14. Bulow B., Hagmar L., Orbaek P., Osterberg K., Erfurth E.M. High incidence of mental disorders, reduced mental well-being and cognitive function in hypopituitary women with GH deficiency treated for pituitary disease. Clin. Endocrinol. (Oxf.) 2002, 56:183-193.
15. Burman P., Broman J.E., Hetta J., Wiklund I., Erfurth E.M., Hagg E., Karlsson F.A. Quality of life in adults with growth hormone (GH) deficiency: Response to treatment with recombinant human GH in a placebo-controlled 21-month trial. J. Clin. Endocrinol. Metab. 1995, 80:3585-3590.
16. Burman P., Deijen J.B. Quality of life and cognitive function in patients with pituitary insufficiency. Psychother. Psychosom. 1998, 67:154-167.
17. Burman P., Hetta J., Karlsson A. Effect of growth hormone on brain neurotransmitters. Lancet 1993, 342:1492-1493.
18. Burman P., Hetta J., Wide L., Mansson J.E., Ekman R., Karlsson F.A. Growth hormone treatment affects brain neurotransmitters and thyroxine. Clin. Endocrinol. (Oxf.) 1996, 44:319-324.
19. Cherrier M.M., Asthana S., Plymate S., Baker L., Matsumoto A.M., Peskind E., Raskind M.A., Brodkin K., Bremner W., Petrova A., Latendresse S., Craft S. Testosterone supplementation improves spatial and verbal memory in healthy older men. Neurology 2001, 57:80-88.
20. Cherrier M.M., Plymate S., Mohan S., Asthana S., Matsumoto A.M., Bremner W., Peskind E., Raskind M., Latendresse S., Haley A.P., Craft S. Relationship between testosterone supplementation and insulin-like growth factor-I levels and cognition in healthy older men. Psychoneuroendocrinology 2004, 29:65-82.
21. Cohen J. Statistical Power Analysis for the Behavourial Sciences 1977, Academic Press, New York.
22. Day M.D. Autonomic Pharmacology, Experimental and Clinical Aspects 1979, Churchill Livingstone, New York.
23. Degerblad M., Almkvist O., Grunditz R., Hall K., Kaijser L., Knutsson E., Ringertz H., Thoren M. Physical and psychological capabilities during substitution therapy with recombinant growth hormone in adults with growth hormone deficiency. Acta Endocrinol. (Copenh.) 1990, 123:185-193.
24. Deijen J.B., de Boer H., Blok G.J., van der Veen E.A. Cognitive impairments and mood disturbances in growth hormone deficient men. Psychoneuroendocrinology 1996, 21:313-322.
25. Deijen J.B., de Boer H., van der Veen E.A. Cognitive changes during growth hormone replacement in adult men. Psychoneuroendocrinology 1998, 23:45-55.
26. Deijen J.B., Orlebeke J.F., Rijsdijk F.V. Effect of depression on psychomotor skills, eye movements and recognition-memory. J Affect. Disord. 1993, 29:33-40.
27. Dik M.G., Pluijm S.M., Jonker C., Deeg D.J., Lomecky M.Z., Lips P. Insulin-like growth factor-I (IGF-I) and cognitive decline in older persons. Neurobiol. Aging 2003, 24:573-581.
28. Erlanger D.M., Kutner K.C., Jacobs A.R. Hormones and cognition: Current concepts and issues in neuropsychology. Neuropsychol. Rev. 1999, 9:175-207.
29. Ferrando A.A., Sheffield-Moore M., Yeckel C.W., Gilkison C., Jiang J., Achacosa A., Lieberman S.A., Tipton K., Wolfe R.R., Urban R.J. Testosterone administration to older men improves muscle function: Molecular and physiological mechanisms. Am. J. Physiol. Endocrinol. Metab. 2002, 282:E601-E607.
30. Friedlander A.L., Butterfield G.E., Moynihan S., Grillo J., Pollack M., Holloway L., Friedman L., Yesavage J., Matthias D., Lee S., Marcus R., Hoffman A.R. One year of insulin-like growth factor-I treatment does not affect bone density, body composition, or psychological measures in postmenopausal women. J. Clin. Endocrinol. Metab. 2001, 86:1496-1503.
31. Furman K., Ezzat S. Psychological features of acromegaly. Psychother. Psychosom. 1998, 67:147-153.
32. Galatzer A., Aran O., Beit-Halachmi N., Nofar E., Rubitchek J., Pertzelan A., Laron Z. The impact of long-term therapy by a multidisciplinary team on the education, occupation and marital status of growth hormone deficient patients after termination of therapy. Clin. Endocrinol. (Oxf.) 1987, 27:191-196.
33. Gardner D. Synaptic transmission. Neuroscience in Medicine 1995, 75-114. Lippincott, Philadelphia, PA. P.M. Conn (Ed.).
34. Gelding S.V., Taylor N.F., Wood P.J., Noonan K., Weaver J.U., Wood D.F., Monson J.P. The effect of growth hormone replacement therapy on cortisol-cortisone interconversion in hypopituitary adults: Evidence for growth hormone modulation of extrarenal 11 beta-hydroxysteroid dehydrogenase activity. Clin. Endocrinol. (Oxf.) 1998, 48:153-162.
35. Grattan-Smith P.J., Morris J.G., Shores E.A., Batchelor J., Sparks R.S. Neuropsychological abnormalities in patients with pituitary tumours. Acta Neurol. Scand. 1992, 86:626-631.
36. Grunfeld C., Sherman B.M., Cavalieri R.R. The acute effects of human growth hormone administration on thyroid function in normal men. J. Clin. Endocrinol. Metab. 1988, 67:1111-1114.
37. Han V.K. Is the central nervous system a target for growth hormone and insulin-like growth factors?. Acta Paediatr. Suppl. 1995, 411:3-8.
38. Haqq A.M., Stadler D.D., Jackson R.H., Rosenfeld R.G., Purnell J.Q., LaFranchi S.H. Effects of growth hormone on pulmonary function, sleep quality, behavior, cognition, growth velocity, body composition, and resting energy expenditure in Prader-Willi syndrome. J. Clin. Endocrinol. Metab. 2003, 88:2206-2212.
39. Hunt S.M., McKenna S.P., Doward L.C. Preliminary report on the development of a disease-specific instrument for assessing quality of life of adults with growth hormone deficiency. Acta Endocrinol. (Copenh.) 1993, 128(Suppl 2):37-40.
40. Hussain M.A., Schmitz O., Jorgensen J.O., Christiansen J.S., Weeke J., Schmid C., Froesch E.R. Insulin-like growth factor I alters peripheral thyroid hormone metabolism in humans: Comparison with growth hormone. Eur. J. Endocrinol. 1996, 134:563-567.
41. Isidori A.M., Kaltsas G.A., Perry L., Burrin J.M., Besser G.M., Monson J.P. The effect of growth hormone replacement therapy on adrenal androgen secretion in adult onset hypopituitarism. Clin. Endocrinol. (Oxf.) 2003, 58:601-611.
42. Johansson J.O., Larson G., Andersson M., Elmgren A., Hynsjo L., Lindahl A., Lundberg P.A., Isaksson O.G., Lindstedt S., Bengtsson B.A. Treatment of growth hormone-deficient adults with recombinant human growth hormone increases the concentration of growth hormone in the cerebrospinal fluid and affects neurotransmitters. Neuroendocrinology 1995, 61:57-66.
43. Johnston D.G. Growth hormone deficiency and quality of life in hypopituitary adults. Clin. Endocrinol. (Oxf.) 1997, 46:407-408.
44. Jorgensen J.O., Moller J., Skakkebaek N.E., Weeke J., Christiansen J.S. Thyroid function during growth hormone therapy. Horm. Res. 1992, 38(Suppl 1):63-67.
45. Jorgensen J.O., Ovesen P., Juul A., Hansen T.K., Skakkeback N.E., Christiansen J.S. Impact of growth hormone administration on other hormonal axes. Horm. Res. 1999, 51(Suppl 3):121-126.
46. Kalina-Faska B., Kalina M., Koehler B. Effects of recombinant growth hormone therapy on thyroid hormone concentrations. Int. J. Clin. Pharmacol. Ther. 2004, 42:30-34.
47. Kalmijn S., Janssen J.A., Pols H.A., Lamberts S.W., Breteler M.M. A prospective study on circulating insulin-like growth factor-I (IGF-I), IGF-binding proteins, and cognitive function in the elderly. J. Clin. Endocrinol. Metab. 2000, 85:4551-4555.
48. Kranzler J.H., Rosenbloom A.L., Martinez V., Guevara-Aguirre J. Normal intelligence with severe insulin-like growth factor-I deficiency due to growth hormone receptor deficiency: A controlled study in a genetically homogeneous population. J. Clin. Endocrinol. Metab. 1998, 83:1953-1958.
49. Lai Z., Roos P., Zhai O., Olsson Y., Fholenhag K., Larsson C., Nyberg F. Age-related reduction of human growth hormone-binding sites in the human brain. Brain Res. 1993, 621:260-266.
50. Leung K.C., Doyle N., Ballesteros M., Sjogren K., Watts C.K., Low T.H., Leong G.M., Ross R.J., Ho K.K. Estrogen inhibits GH signaling by suppressing GH-induced JAK2 phosphorylation, an effect mediated by SOCS-2. Proc. Natl. Acad. Sci. USA 2003, 100:1016-1021.
51. Lijffijt M., Van Dam P.S., Kenemans J.L., Koppeschaar H.P., de Vries W.R., Drent M.L., Wittenberg A., Kemner C. Somatotropic-axis deficiency affects brain substrates of selective attention in childhood-onset growth hormone deficient patients. Neurosci. Lett. 2003, 353:123-126.
52. Lynch S., Merson S., Beshyah S.A., Skinner E., Sharp P., Priest R.G., Johnston D.G. Psychiatric morbidity in adults with hypopituitarism. J. R. Soc. Med. 1994, 87:445-447.
53. Martinez J.L., Kesner R.P. Learning and Memory: A Biological View 1991, Academic Press, San Diego.
54. McGauley G., Cuneo R., Salomon F., Sonksen P.H. Growth hormone deficiency and quality of life. Horm. Res. 1996, 45:34-37.
55. Moller J., Jorgensen J.O., Moller N., Christiansen J.S., Weeke J. Effects of growth hormone administration on fuel oxidation and thyroid function in normal man. Metabolism 1992, 41:728-731.
56. Morley J.E., Kaiser F., Raum W.J., Perry H.M., Flood J.F., Jensen J., Silver A.J., Roberts E. Potentially prodictive and manipulable blood serum correlates of aging in the healthy human male: Progressive decreases in bioavailable testosterone, dehydroepiandrosterone sulfate, and the ratio of insulin-like growth factor-I to growth hormone. Proc. Natl. Acad. Sci. USA 1997, 94:7537-7542.
57. Nyberg F. Growth hormone in the brain: Characteristics of specific brain targets for the hormone and their functional significance. Front. Neuroendocrinol. 2000, 21:330-348.
58. Page R.C., Hammersley M.S., Burke C.W., Wass J.A. An account of the quality of life of patients after treatment for non-functioning pituitary tumours. Clin. Endocrinol. (Oxf.) 1997, 46:401-406.
59. Paolisso G., Ammendola S., Del Buono A., Gambardella A., Riondino M., Tagliamonte M.R., Rizzo M.R., Carella C., Varricchio M. Serum levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 in healthy centenarians: Relationship with plasma leptin and lipid concentrations, insulin action, and cognitive function. J. Clin. Endocrinol. Metab. 1997, 82:2204-2209.
60. Papadakis M.A., Grady D., Black D., Tierney M.J., Gooding G.A., Schambelan M., Grunfeld C. Growth hormone replacement in healthy older men improves body composition but not functional ability. Ann. Intern. Med. 1996, 124:708-716.
61. Papadakis M.A., Grady D., Tierney M.J., Black D., Wells L., Grunfeld C. Insulin-like growth factor-I and functional status in healthy older men. J. Am. Geriatr. Soc. 1995, 43:1350-1355.
62. Parsons M.W., Gold P.E. Glucose enhancement of memory in elderly humans: An inverted-U dose-response curve. Neurobiol. Aging 1992, 13:401-404.
63. Peace K.A., Orme S.M., Padayatty S.J., Godfrey H.P., Belchetz P.E. Cognitive dysfunction in patients with pituitary tumour who have been treated with transfrontal or transsphenoidal surgery or medication. Clin. Endocrinol. (Oxf.) 1998, 49:391-396.
64. Pepeu G., Spignoli G., Giovanni M.G., Magnani M. The relationship between the behavioral effects of cognition-enhancing drugs and brain acetylcholine. Pharmacopsychiatry 1989, 22:116-119.
65. Richert S., Strauss A., Fahlbusch R., Oeckler R., von Werder K. Psychopathologic symptoms and personality traits in patients with florid acromegaly. Schweiz. Arch. Neurol. Psychiatr. 1987, 138:61-86.
66. Rikken B., van Busschbach J., le Cessie S., Manten W., Spermon T., Grobbee R., Wit J.M. Impaired social status of growth hormone deficient adults as compared to controls with short or normal stature: Dutch Growth Hormone Working Group. Clin. Endocrinol. (Oxf.) 1995, 43:205-211.
67. Rodriguez-Arnao J., Perry L., Besser G.M., Ross R.J. Growth hormone treatment in hypopituitary GH deficient adults reduces circulating cortisol levels during hydrocortisone replacement therapy. Clin. Endocrinol. (Oxf.) 1996, 45:33-37.
68. Rollero A., Murialdo G., Fonzi S., Garrone S., Gianelli M.V., Gazzerro E., Barreca A., Polleri A. Relationship between cognitive function, growth hormone and insulin-like growth factor-I plasma levels in aged subjects. Neuropsychobiology 1998, 38:73-79.
69. Rosen T., Wiren L., Wilhelmsen L., Wiklund I., Bengtsson B.A. Decreased psychological well-being in adult patients with growth hormone deficiency. Clin. Endocrinol. (Oxf.) 1994, 40:111-116.
70. Ross J.L., Feuillan P., Kushner H., Roeltgen D., Cutler G.B. Absence of growth hormone effects on cognitive function in girls with Turner syndrome. J. Clin. Endocrinol. Metab. 1997, 82:1814-1817.
71. Sartorio A., Molinari E., Riva G., Conti A., Morabito F., Faglia G. Growth hormone treatment in adults with childhood onset growth hormone deficiency: Effects on psychological capabilities. Horm. Res. 1995, 44:6-11.
72. Soares C.N., Musolino N.R., Cunha N.M., Caires M.A., Rosenthal M.C., Camargo C.P., Bronstein M.D. Impact of recombinant human growth hormone (RH-GH) treatment on psychiatric, neuropsychological and clinical profiles of GH deficient adults: A placebo-controlled trial. Arq Neuropsiquiatr. 1999, 57:182-189.
73. Stouthart P.J., Deijen J.B., Roffel M., Delemarre-van de Waal HA Quality of life of growth hormone (GH) deficient young adults during discontinuation and restart of GH therapy. Psychoneu-roendocrinology 2003, 28:612-626.
74. Swords F.M., Carroll P.V., Kisalu J., Wood P.J., Taylor N.F., Monson J.P. The effects of growth hormone deficiency and replacement on glucocorticoid exposure in hypopituitary patients on cortisone acetate and hydrocortisone replacement. Clin. Endocrinol. (Oxf.) 2003, 59:613-620.
75. Thornton P.L., Ingram R.L., Sonntag W.E. Chronic [D-Ala2]-growth hormone-releasing hormone administration attenuates age-related deficits in spatial memory. J. Gerontol. A Biol. Sci. Med. Sci. 2000, 55:B106-B112.
76. Turchi J., Sarter M. Bidirectional modulation of basal fore-brain N-methyl-D-aspartate receptor function differentially affects visual attention but not visual discrimination performance. Neuroscience 2001, 104:407-417.
77. Veldhuis J.D., Metzger D.L., Martha P.M., Mauras N., Kerrigan J.R., Keenan B., Rogol A.D., Pincus S.M. Estrogen and testosterone, but not a nonaromatizable androgen, direct network integration of the hypothalamo-somatotrope (growth hormone)-insulin-like growth factor-I axis in the human: Evidence from pubertal pathophysiology and sex-steroid hormone replacement. J. Clin. Endocrinol. Metab. 1997, 82:3414-3420.
78. Vitiello M.V., Merriam G.R., Mazzoni G. Growth hormone releasing hormone treatment improves cognitive function in healthy older men and women. Gerontologist 2003, 43:S1-S4.
79. Vitiello M.V., Merriam G.R., Moe K.E., Drolet G., Barsness S., Kletke M., Schwartz R.S. IGF-I correlates with cognitive function in healthy older men and estrogenized women. Gerontologist 1999, 39:6.
80. Wallymahmed M.E., Foy P., MacFarlane I.A. The quality of life of adults with growth hormone deficiency: Comparison with diabetic patients and control subjects. Clin. Endocrinol. (Oxf.) 1999, 51:333-338.
81. Wiren L., Johannsson G., Bengtsson B.A. A prospective investigation of quality of life and psychological well-being after the Ideficiency during childhood. J. Clin. Endocrinol. Metab. 2001, 86:3494-3498.